Oxidation of low density lipoproteins from patients with renal failure or renal transplants

scientific article published on 01 July 1995

Oxidation of low density lipoproteins from patients with renal failure or renal transplants is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1038/KI.1995.288
P698PubMed publication ID7564083

P2093author name stringR J Walker
M C Robertson
M J Ball
S A Stapley
W H Sutherland
P2860cites workOxidation of lipoprotein Lp(a). A comparison with low-density lipoproteinsQ67897493
Risk factors for accelerated atherosclerosis in renal transplant recipientsQ68142393
Lipoprotein abnormalities in hyperlipidemic and normolipidemic men on hemodialysis with chronic renal failureQ68174243
The antioxidant butylated hydroxytoluene protects against atherosclerosisQ68183264
Hemodialysis membrane-induced activation of phagocyte oxidative metabolism detected in vivo and in vitro within microamounts of whole bloodQ69793840
Trace elements and lipid peroxidation abnormalities in patients with chronic renal failureQ70181338
Oxidation of low-density lipoproteins: intraindividual variability and the effect of dietary linoleate supplementationQ70574095
Endothelial and smooth muscle cells alter low density lipoprotein in vitro by free radical oxidationQ70580559
Thiobarbituric Acid Reactive Material in Uremic BloodQ71070627
Enhanced LDL oxidation in uremic patients: an additional mechanism for accelerated atherosclerosis?Q72473939
LDL oxidation in patients with severe carotid atherosclerosis. A study of in vitro and in vivo oxidation markersQ72858488
Autoantibodies against oxidatively-modified LDL in uremic patients undergoing dialysisQ72898129
Effects of oleate-rich and linoleate-rich diets on the susceptibility of low density lipoprotein to oxidative modification in mildly hypercholesterolemic subjectsQ33891495
Minimally modified low density lipoprotein stimulates monocyte endothelial interactionsQ34248823
Effects of ACE inhibitors on oxidation of human low density lipoproteinQ34345963
Antiatherogenic effect of probucol unrelated to its hypocholesterolemic effect: evidence that antioxidants in vivo can selectively inhibit low density lipoprotein degradation in macrophage-rich fatty streaks and slow the progression of atherosclerosQ34360883
Oxidatively modified low density lipoproteins: a potential role in recruitment and retention of monocyte/macrophages during atherogenesisQ34620005
Plasma High-Density Lipoprotein Concentrations in Chronic-Hemodialysis and Renal-Transplant PatientsQ40074815
Serum lipoprotein abnormalities in renal allograft recipientsQ40164159
Pro-oxidant effects of lipoxygenase-derived peroxides on the copper-initiated oxidation of low-density lipoproteinQ42793021
Lipid peroxides and atherosclerosisQ43379861
Simultaneous determination of α-tocopherol and retinol in plasma or red cells by high pressure liquid chromatographyQ44534536
Effect of vitamin C and E supplementation on susceptibility of plasma lipoproteins to peroxidation induced by acute smokingQ45197147
Oxidation resistance, oxidation rate, and extent of oxidation of human low-density lipoprotein depend on the ratio of oleic acid content to linoleic acid content: studies in vitamin E deficient subjects.Q54231348
Effect of dietary monounsaturated and polyunsaturated fatty acids on the susceptibility of plasma low density lipoproteins to oxidative modificationQ54272815
Vitamin E content and low density lipoprotein oxidizability induced by free radicals.Q54326516
Autoantibody against oxidised LDL and progression of carotid atherosclerosisQ59704366
Susceptibility to low-density lipoprotein oxidation and coronary atherosclerosis in manQ67516427
Low density lipoprotein composition and oxidizability in coronary disease--apparent favourable effect of beta blockersQ67524940
Effect of hemodialysis on lipid peroxidation and antioxidant system in patients with chronic renal failureQ67582315
P433issue1
P407language of work or nameEnglishQ1860
P304page(s)227-236
P577publication date1995-07-01
P1433published inKidney InternationalQ6404823
P1476titleOxidation of low density lipoproteins from patients with renal failure or renal transplants
P478volume48

Reverse relations

cites work (P2860)
Q45107476A prudent algorithm for hyperlipoproteinemia in renal transplant recipients
Q73712824Alpha-tocopherol supplementation decreases the oxidative susceptibility of LDL in renal failure patients on dialysis therapy
Q73098816An hydroalcoholic extract of curcuma longa lowers the apo B/apo A ratio. Implications for atherogenesis prevention
Q30490221Astaxanthin vs placebo on arterial stiffness, oxidative stress and inflammation in renal transplant patients (Xanthin): a randomised controlled trial.
Q44491073Beneficial effects of fluvastatin on progressive renal allograft dysfunction
Q57750639Cardiovascular disease in renal transplantation: Management by statins
Q73423970Cholesterol feeding accentuates the cyclosporine-induced elevation of renal plasminogen activator inhibitor type 1
Q30490204Comparison of markers of oxidative stress, inflammation and arterial stiffness between incident hemodialysis and peritoneal dialysis patients--an observational study.
Q46873899Effect of calcineurin inhibitors on low-density lipoprotein oxidation
Q34137545Effect of hemodialysis and peritoneal dialysis on redox status in chronic renal failure patients: a comparative study
Q44297695Evaluation of the atherogenic tendency of lipids and lipoprotein content and their relationships with oxidant-antioxidant system in patients with psoriasis
Q61864856Fatty acid composition in low-density lipoproteins from renal transplant recipients
Q43963171Fatty acid composition of low-density lipoprotein in renal transplant recipients treated with cyclosporine.
Q86978354Fluvastatin Decreases Oxidative Stress in Kidney Transplant Patients
Q77340490HDL composition and HDL antioxidant capacity in patients on regular haemodialysis
Q46865479Hemodialysis reduces inhibitory effect of plasma ultrafiltrate on LDL oxidation and subsequent endothelial reactions
Q35764605Immunological evidence for hypochlorite-modified proteins in human kidney
Q37048963Lipid Profile In Transplant Patients: A Clinical Study
Q34348769Lipid peroxidation in aging and age-dependent diseases
Q45958503Low-density lipoprotein oxidizability and the alteration of its fatty acid content in renal transplant recipients treated with cyclosporine/tacrolimus.
Q41071344Macrophage glutathione content and glutathione peroxidase activity are inversely related to cell-mediated oxidation of LDL: in vitro and in vivo studies
Q50961766Oxidation of low density lipoprotein in hemodialysis patients: effect of dialysis and comparison with matched controls.
Q74014108Oxidation of low-density lipoprotein and atherosclerosis in chronic renal failure
Q61864861Oxidation of low-density lipoproteins in renal transplant recipients
Q43963175Oxidation of low-density lipoproteins in renal transplant recipients treated with tacrolimus.
Q33788653Oxidized LDL, glomerular mesangial cells and collagen
Q34310277Pathophysiology of oxidative stress in diabetes mellitus
Q28076119Post-transplant dyslipidemia: Mechanisms, diagnosis and management
Q73487574Protective effects of high-density lipoprotein against oxidative stress are impaired in haemodialysis patients
Q38298703Role of CAGA boxes in the plasminogen activator inhibitor-1 promoter in mediating oxidized low-density lipoprotein-induced transcriptional activation in mesangial cells
Q47112177Status of antioxidant and homocysteine-lowering vitamins related to cardiovascular diseases in hemodialysis patients.
Q73229423Susceptibility of VLDL to oxidation in patients on regular haemodialysis

Search more.